Product Images Aspirin And Extended-release Dipyridamole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Aspirin And Extended-release Dipyridamole NDC 42291-116 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

25 200 - 116 60 25mg 200mg

25 200 - 116 60 25mg 200mg

Aspirin and extended-release Dipyridamole capsules are available in unit-of-use containers of 60 capsules. Each capsule contains 200mg dipyridamole in extended-release form and 25mg aspirin in immediate-release sugar-coated tablet form. The usual dosage is available in the accompanying prescription information. It is a prescription medication and should be stored between 20 C to 25C (68F to 77F) and can be excused between 15C to 30C (59F to 86F). Manufactured by Amneal Pharmaceuticals of NY, LLC and is distributed by AVKARE with the latest revision done in January 2019. It is important to keep them away from children and protect them from excessive moisture.*

chem struc DP - aspirin and extended release dipyridamole capsules 1

chem struc DP - aspirin and extended release dipyridamole capsules 1

This is a chemical compound with a molecular weight of 504.63 g/mol and its chemical formula is C24H40Ng0O4. It is not clear what the compound's name or purpose is as only the chemical formula and molecular weight are provided.*

chem struc ASP - aspirin and extended release dipyridamole capsules 2

chem struc ASP - aspirin and extended release dipyridamole capsules 2

Figure 1 - aspirin and extended release dipyridamole capsules 3

Figure 1 - aspirin and extended release dipyridamole capsules 3

This is a graph showing the cumulative stroke rate for different treatment groups over a period of 26 months. The treatment groups include aspirin and extended-release dipyridamole (ER-DP) and placebo. The dosage regimen for all groups is b.i.d. (twice a day). The x-axis represents the months of follow-up and the y-axis represents the percentage of cumulative stroke rate.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.